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ABSTRACT 
 
Increased Fat Oxidation in 3T3-L1 Adipocytes through  
Forced Expression of UCP1. (August 2005) 
Santhosh Palani, B.Tech., University of Madras 
Chair of Advisory Committee: Dr. Arul Jayaraman 
 
 
 
 Obesity is a chronic condition that primarily develops from an 
increase in body fat in the form of white adipose tissue (WAT) mass. The 
resulting adiposity is a risk factor for many diseases, including type 2 
diabetes (T2D), cardiovascular diseases, and some forms of cancer. Reducing 
WAT mass by targeted modulation of metabolic enzymes in fat cell 
metabolism is an attractive molecular therapeutic alternative to dietary 
approaches. In the present study, we exogenously up-regulate a novel 
respiratory uncoupling protein to increase substrate oxidation, and thereby 
control adipocyte fatty acid content.  
 Increasing molecular evidence points to a family of uncoupling 
proteins (UCPs) playing an important role in adipocyte fat metabolism. Of 
specific interest is UCP1, which in brown adipocytes mediates energy 
dissipation as heat by de-coupling respiration and ATP synthesis. UCP1 is 
minimally expressed in white adipose tissue (WAT). We hypothesize that 
controlled expression of UCP1 in WAT will result in enhanced fatty acid 
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oxidation to compensate for reduced ATP synthesis. We used a Tet-Off 
retroviral transfection system to express UCP1, with doxycycline being used 
to control the extent of expression. UCP1 cDNA was cloned into pRevTRE 
and was stably transfected into 3T3-L1 preadipocytes prior to differentiating 
them into adipocytes. A reporter gene (EGFP) was also transfected in 
parallel to optimize the transfection and preadipocyte differentiation 
conditions as well as to demonstrate regulated expression. Metabolite 
measurements showed that the UCP1-expressing adipocytes accumulated 
83% less triglyceride and 85 % free fatty acids while maintaining constant 
ATP levels. These results suggest UCP1 and other metabolic enzymes as 
potential targets for development of pharmacological agents for the 
treatment of obesity and related disorders.  
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INTRODUCTION 
Obesity is a chronic condition that develops due to excess 
accumulation of fats in adipose tissue and skeletal muscle. It increases the 
risk of many diseases including Type II diabetes and cardiovascular 
diseases. In the US, one out of three adults is obese and among African 
Americans and Hispanics one out of two adults is obese (1). Current dietary 
therapies are mostly reversible and only few of the patients maintain their 
weight loss. Obesity drug development has mainly concentrated on reducing 
food intake and altering whole body metabolism. As of 2001, only 2 drugs 
(siburtramine and orlisat) have been approved for obesity treatment, but 
even these drugs suffer from numerous side effects (2).  
Adipose tissue is a connective tissue that functions as a storage site 
for triglycerides. It is found in two forms: BAT and WAT. Obesity develops 
due to the expansion and increase in the number of fat cells in WAT. Adipose 
tissue stores fats in the form of large lipid droplets. When the body needs 
stored energy, adipocytes respond by undergoing lipolysis, breaking of lipids 
in to free fatty acids and transporting it to the necessary tissues through the 
plasma; 
Dissipation of the proton gradient, also called the proton leak in the  
___________________ 
This thesis follows the style and format of The Journal of Biological Chemistry. 
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inter membrane space of mitochondria has been attributed to the family of  
uncoupling proteins UCP1, UCP2 and UCP3 (3). Cold bearing animals tend 
to produce heat in brown adipose tissue (BAT) by dissipating their proton 
gradient and Uncoupling Protein 1 (UCP1) is the protein which has been 
implicated in this process (4). Adults have very less percentage of BAT 
compared to white adipose tissue (WAT). Discovery of uncoupling proteins 
has led to a significant interest in approaches to treat obesity by increasing 
the overall metabolic rate of the body (5). Proteins analogous in DNA 
sequence to UCP1 have been found in WAT, UCP2 and UCP3. While UCP2 
is expressed in numerous tissues, UCP3 is largely found in skeletal muscles 
(6). However, the mechanism by which these UCPs dissipate the proton 
gradient is not fully understood.  
Uncoupling proteins are inactive in their native state as they are 
bound by purine nucleotides (GTP, GDP, ATP, and ADP). They get activated 
when their channel thickness is constricted by fatty acids, which also act as 
a proton carrier through the UCP channel. This contraction of the UCP 
channel dislocates the purine nucleotides from the UCP, and initiates 
uncoupling (7). Dissipation of the proton gradient causes a reduction in the 
synthesis of ATP which leads to an increase in whole cell metabolic rate 
which induces the cell to break down macromolecules to produce more 
energy substrates to meet up with ATP demands. 
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The goal of this study is to develop an efficient transfection system to 
modulate a gene of interest for desired expression levels, and to stably 
transfect UCP1 and a reporter gene (EGFP) into preadipocytes using the 
developed transfection system for expression. An uncontrolled uncoupling 
activity inside the cell can lead to scarcity of ATP molecules, resulting in 
various physiological disorders including insulin resistance. 
We propose to use a retroviral vector for transfection which will 
provide a unique way to modulate gene expression using a chemical inducer 
such as doxycycline in a dose dependent manner (8). 
To develop a fully functional retroviral vector system, a gene-carrier 
plasmid (pRevTRE-Gene) and a Tet Response Element (TRE) binding 
regulatory plasmid was transfected into 3T3-L1 preadipocytes. Developing 
double stable cells expressing both plasmids is a complex and tedious 
process, but the transfection is highly efficient in making stable cells 
compared to other plasmids having constitutive promoters (9). 
Uncoupling mechanism of UCP1 has been vastly studied in BAT, but 
less information is available regarding its activity in WAT. Experimental 
evidence for UCP2 uncoupling is yet to be revealed. Hence this study will 
help understand the uncoupling behavior of these UCPs, as well as will 
provide insights into treating genetic disorders like obesity and insulin 
resistance by gene therapy. 
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Metabolism of Adipocytes- Till the 1980’s, WAT was considered only as a 
storage depot. But recent findings show that WAT secretes and responds to a 
variety of endocrine, paracrine and autocrine factors which affect whole body 
and WAT metabolism (10). WAT fat metabolism comprises of both anabolic 
and catabolic reactions (Fig. 1). The anabolic reactions in adipocytes, 
lipogenesis, consists of synthesis of long chain fatty acids (LCFA), and their 
esterification into triglycerides, stored in the form of lipid droplets. The 
complementary catabolic reactions, lipolysis, involves the breaking down of 
triglycerides into free fatty acids and their subsequent oxidation into Acetyl- 
CoA to act as an energy substrate for the cell. Studies indicate that this 
process of lipolysis can be stimulated by cytokine signaling. During injury, 
TNF- has been shown to stimulate lipolysis in adipose tissue. This process 
increases the plasma free fatty acid concentration to supply energy during 
inflammation to the injured tissues (11). Induced TNF- stimulation of 
lipolysis, to treat obesity increases the free fatty acid concentration in blood, 
thereby causing insulin resistance in various tissues. Also, TNF- serine 
phosphorylates IRS1&2, and aggravates insulin signaling. 
Expansion of adipose mass is carried out in two steps, hypertrophy, an 
increase in cells size followed by hyperplasia, an increase in cell number. It’s 
shown that both in human and non-human, hypertrophy always precede 
hyperplasia in a cyclic manner. This concept is supported by the “critical fat 
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cell size” hypothesis (12), which claims that adipocytes grow to a critical size 
and then recruit other precursor cells (preadipocytes) to proliferate and 
differentiate into mature adipocytes.  
Mitochondria provide the main source of energy for the adipocytes, 
through oxidation of three classes of energy substrates, amino acids, fatty 
acids and monosaccharide. These substrates branch into the glycolysis 
pathway for oxidation into CO2 and H2O through the Krebs cycle and 
electron transport chain (ETC) (13).  
Complexes in the ETC pump H+ from the matrix to the 
intermemberane space of the mitochondria, thereby creating a proton 
gradient. The energy derived from this gradient is used by the F1-F0 ATP 
synthase to produce ATP by a process known as oxidative phosphorylation. 
The backflow of protons into the matrix dissipates the gradient and results 
in lesser production of ATP. It is observed that not all the energy supplied by 
the substrate is converted to ATP, as few non-protein membrane pores at the 
protein-lipid interfaces mediate the transfer of protons across the inner 
membrane. Protein mediated dissipation of the proton gradient is also called 
uncoupling and was first observed in BAT in 1964 (14). Cold bearing animals 
tend to dissipate their proton gradient to produce heat in BAT and the 
protein which creates the leak was called thermogenin, currently termed as 
Uncoupling Protein 1 (UCP1). 
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Fig. 1. Metabolic pathway chart of adipocytes showing glycolysis, 
TCA cycle, lipolysis, lipogenesis, UCP activation and ATP synthesis 
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Adipocyte Differentiation- The early molecular events engaged in the 
conversion of primitive mesenchymal precursor cells to committed cell lines 
are completely unknown. Due to this reason, most of the research on 
adipocytes is done with predetermined clonal cell lines or preadipocytes. 
3T3-L1 preadipocytes are isolated from non-clonal Swiss 3T3 cells, and have 
morphology similar to fibroblasts. The differentiation steps (15) for the 
formation of mature adipocytes from preadipocytes are clearly defined (Fig. 
2). The first step in differentiation is the proliferation of the preadipocytes to 
reach confluence. The next step is the growth arrest induced by contact 
inhibition between neighboring preadipocytes.  
This step also involves the activation of the transcription factors (TF) 
CCAAT/ enhancer binding protein  (C/EBP) and C/EBP (16). These 
transcription factors activate other transcription factors like (Peroxisome 
Proliferator activated receptor  (PPAR ) and C/EBP, which are the main 
TF regulating fat cell differentiation. Following growth arrest, preadipocytes 
undergo two rounds of mitotic division known as clonal expansion, which 
concurs with the activation of PPAR  and C/EBP.  After clonal expansion, 
preadipocytes undergo a second growth arrest, followed by differentiation 
into young adipocytes, which grow in size to become mature adipocytes.  
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Fig. 2. Features of adipocyte differentiation  
 
 
 
The process of adipocyte differentiation is highly controlled several 
transcription factors (17). These transcription factors are expressed in a 
cascade in which C/EBP and C/EBP are the first ones to get activated. 
They induce the expression of PPAR, which further activates C/EBP. 
C/EBP in turn activates PPAR through a feedback pathway to maintain 
the differentiated state of the adipocytes. It is observed that PPAR is also 
activated by another transcription factor Adipocyte Determination and 
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Differentiation dependent factor 1(ADD1) or Sterol regulatory element 
binding protein 1(SREBP1) (18). 
 
Inhibitors and Inducers of Adipogenesis- It has been observed by several 
empirical methods that hormones including, Insulin, Insulin like growth 
factor 1(IGF-1), Glucocorticoid, Triiodothyronine and cAMP facilitate the 
differentiation of preadipocytes in vitro (19).  Insulin/IGF-1 activates the 
Insulin like growth factor receptor (IGFR) and signals through the RAS and 
Protein Kinase B (PKB) pathways to induce adipogenesis (Fig. 3) (20).  
 
 
 
 
Fig. 3. Inhibitors and inducers of adipogenesis 
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Glucocorticoid acts on the Glucocorticoid receptor to induce the 
expression of C/EBP and also to inhibit the expression of Preadipocyte 
factor 1 (pref-1) (21). Methylisobutylxanthine (MIX) activates cAMP and 
induces expression of C/EBP through the cAMP element binding protein 
(CREB) pathway (22).  Combination of Glucocorticoid, MIX and insulin is 
considered to be the optimum mixture for efficient differentiation of 
preadipocytes. 
A variety of cytokines like TNF-, IL-1 and growth factors like PDGF, 
FGF, EGF (5) have found to inhibit adipocyte differentiation (23, 24). These 
growth factors and cytokines activate the Mitogen Activated Protein Kinase 
(MAPK) pathway, which phosphorylates PPAR and its hetrodimerization 
nuclear receptor retinoid X receptor (RXR), leading to inhibition of 
adipogenesis. Pref-1 is a surface glycoprotein shown to inhibit preadipocyte 
differentiation. Pref-1 can also be released as an autocrine or a paracrine 
factor to regulate adipogenesis. The receptor for Pref-1 is completely 
unknown. 
 
UCP1 Signaling Pathway in BAT- BAT dissipates its energy by uncoupling 
to regulate the body temperature when exposed to cold. The pathway 
regulating UCP activity is well understood (Fig. 4). When cold is sensed by 
the brain, it activates series of sympathetic nerves to produce noradrenaline 
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(25).  Noradrenaline activates the -adrenergenic receptor, which in turn 
activates CREB through cAMP and Protein Kinase A.    CREB 
phosphorylation induces the expression of PPAR coactivator 1 (PGC-1) 
and Type II thyroxine deiodinase (DII). PGC-1 activates the transcription 
factors PPAR and RXR, RXR and RAR located on the UCP1 enhancer. DII 
in turn converts tetraiodothronine (T4) to triiodothyronine (T3), the agonist 
for a thyroid hormone receptor, which further increases expression levels of 
UCP1. 
 
 
 
 
 
Fig. 4. Adaptive thermogenesis 
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Protein kinase A also activates hormone sensitive lipase which increases the 
concentration of fatty acids and leads to UCP1 activation (Fig. 1). PGC-1 also 
activates nuclear respiratory factors (NRF1, NRF2) which lead to the 
activation of genes for mitochondrial biogenesis and function (26). 
 
Uncoupling Mechanism of UCP1- While the activation of UCP1 is well 
studied, UCP1 uncoupling mechanism is poorly understood. UCP1 is inactive 
in its native state as it is bound by purine nucleotides (GTP, ATP, GDP, and 
GTP). Threshold concentrations of free fatty acids allosterically displace 
purine nucleotides and activate UCP1 uncoupling. There are two 
mechanisms currently in literature which explains UCP1 uncoupling (27).  
In one model (28), UCP1 is considered as a true H+ carrier across the 
mitochondrial inner membrane (Fig. 5A). FFA binds to UCP1 in a way that 
their carboxylic groups act as H+ donors/acceptors to resident carboxylic 
groups. Histidine residues are speculated to be the final H+ carrier before 
the proton is released into the matrix. In the other model, UCP1 is 
considered as a fatty acid anion carrier (Fig. 5B). UCP1 carries the 
deprotonated fatty acid across the membrane to the intermembrane space 
(29). In the intermembrane space, FFA gets protonated and sent back to the 
matrix through a flip-flop mechanism. It has been recently shown that the 
mechanism of uncoupling can change depending on the fatty acid 
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concentration. In the presence of small amount of FFA, UCP1 acts mainly as 
an H+ carrier. With high FFA concentration, UCP1 performs as a FFA 
carrier (30). 
 
 
 
 
Fig. 5(A). UCP1 as a proton carrier; (B). UCP1 as a FFA carrier- 
(adapted from (28)) 
 
 
Functional Roles of UCPs- UCP2 and UCP3 are homologues of UCP1 found 
in WAT and share 56% and 57% DNA sequence similarity to UCP1 
respectively (31). In addition, UCP2 and UCP3 have 71% homology as well. 
The question whether UCP2 and UCP3 are novel uncouplers is still 
unanswered. Studies of UCP1, UCP2 and UCP3 activity in liposomes (32) 
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and yeast confirmed their abilities to dissipate the proton gradient (Table 1). 
Studies of UCP1 activity in transgenic mice showing their respiration 
uncoupling behavior; interruption of the murine UCP1 gene demonstrating 
their role in adaptive thermogenesis confirmed UCP1 as a novel uncoupler.   
Unlike UCP1, presence of UCP2 and UCP3 in humans has been 
attributed to the suppression of reactive oxygen species in the mitochondria 
rather than playing a role as uncouplers. Active electron transport chain 
produces lots of free electrons which react with oxygen to form reactive 
oxygen species. Respiration is connected with the production of reactive 
oxygen species (ROS). 
 
 
TABLE 1 
Different roles of uncoupling proteins (UCPs) (adapted from (33)) 
Method UCP1 UCP2 UCP3 
Liposome Proton leak Proton leak Proton leak 
Yeast Proton leak Proton leak Proton leak 
Transgenic mice Respiration 
uncoupling 
Not determined Proton leak 
-/- mice Cold-induced 
Thermogenesis,  
No ROS 
scavenging 
No ROS 
scavenging 
Normal mice Cold-induced 
thermogenesis 
ROS scavenging, 
Fatty acid 
oxidation 
ROS scavenging, 
Fatty acid 
oxidation 
Human genetics Body fat content Resting  
metabolic rate 
Resting  
metabolic rate 
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It is known that mild uncoupling of the proton gradient by UCP2 and 
UCP3 helps in suppressing the production of ROS (34).  Interruption of the 
UCP2 and UCP3 gene by knockout studies stimulated the production of ROS 
validating their function (34). Recently, UCP2 and UCP3 have been also 
related to the maintenance of resting metabolic rate (33). 
 
The RevTET-On/Off Transfection System- The commercially available Tet 
On/Off system is a regulated, high level gene expression system (35). In the 
Tet-Off system gene expression is turned on when tetracycline or doxycycline 
is removed from the culture medium, whereas in the Tet-On system gene 
expression is turned on when doxycycline is added to the system (Fig. 6). 
Both systems provide variation in gene expression with varying 
concentrations of doxycycline (36) and provide extremely tight on/off 
regulation without any background or leaky expression. The binding 
between the Tet transcription factor and the response element is very 
specific (37). The system can provide high induction levels and fast response 
times. Expression levels obtained by the Tet system is more than expression 
levels obtained from CMV promoter or other constitutive promoters (37). The 
inducer doxycycline is well characterized, inexpensive and yields 
reproducible results. In both systems the antibiotics concentration used is 
far below cytotoxic levels. The Tet on/off vector system when fused with a 
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retroviral cassette yields a RevTet on/off system. This system provides stable 
transfection of gene into any dividing cell line. The transfection efficiency of 
the RevTet on/off is very high (36).   
 
 
 
Fig. 6(A) Tet Off gene expression system; (B) Tet On gene expression 
system (38) 
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PROBLEM STATEMENT AND SPECIFIC AIMS 
Hypothesis- Forced expression of uncoupling protein 1 in white adipose 
tissue will decrease the levels of ATP synthesis, causing an increase in the 
whole cell metabolic rate of the cell through increased fat oxidation. 
The purpose of this study are to develop and characterize a defined 
experimental system for studying adipocyte metabolism, to develop an 
efficient transfection for modulating gene of interest; and stably transfect 
UCP1 and a reporter gene (EGFP) into preadipocytes using the developed 
transfection technique. The various steps involved in the study are briefly 
stated below: 
 
Specific Aim 1- To develop and characterize a defined experimental system 
for transfection of a gene of interest into adipocytes, in order to obtain 
regulated, high expression. 
1. Optimization of cell culture protocol for preadipocytes. 
2. Develop expression construct of pRevTRE-EGFP from pRevTRE 
and pEGFP. 
3. Optimization of retroviral vector transfection conditions.   
4. Transfection of pRevTET-On into preadipocytes.  
5.  Obtain stably expressing cell lines by G418 selection 
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6. Transfection of pRevTRE-EGFP into preadipocytes using the 
optimized conditions. 
7. Obtaining double stable cell lines expressing EGFP by hygromycin 
selection. 
8. Optimize differentiation conditions for preadipocytes expressing 
EGFP. 
9. Perform doxycycline assay to regulate the gene expression levels of 
EGFP. 
10.  Perform TG, FFA and ATP assay to characterize adipocyte 
behavior. 
11.  Repeat the assay on EGFP cells and compare with the control. 
12. Perform lipolysis assay on EGFP cells.  
 
Specific Aim 2- To use the developed experimental system to transfect UCP1 
into preadipocytes and to characterize their behavior 
1. Develop expression construct of pRevTRE-UCP1 from pRevTRE 
and pCmv-Sport6-UCP1 
2. Transfection of pRevTRE-UCP1 into preadipocytes using the 
optimized conditions 
3. Obtain double stable cell lines expressing UCP1 by hygromycin 
selection. 
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4. Optimize differentiation conditions for preadipocytes expressing 
UCP1 
5. Perform TG, FFA and ATP assay and compare it with the control. 
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MATERIALS AND METHODS 
 
 
Optimization of Cell Culture Protocol for Increased Differentiation of 
Preadipocytes-3T3-L1 preadipocytes (Passage 2) were seeded on T-25 flasks 
with different seeding densities (1*10^4 to 2.5*10^5 cells/T-25flask). Growth 
medium (DMEM, Bovine Serum [10%]) was replenished every 48 hours till 
the cells reach confluence (Day 0). The cells were kept in growth medium for 
an additional 2 days to initiate natural differentiation. On day 2, cells were 
exposed to differentiation medium 1(DMEM containing insulin, Fetal Bovine 
Serum (FBS) [10%], isobutylmethylxanthine (IBMX) [1uM] and 
dexamethasone) [0.5 mM] to supply hormonal inducers for differentiation. 
The medium was changed to differentiation medium 2(DMEM, insulin 
[1g/ml], FBS [10%]) on day 4 and incubated for two days to maintain their 
differentiation state. Typically, at the end of this exposure, young adipocytes 
were observed. Adipocytes were maintained in maintenance medium 
(DMEM, FBS [10%]) for up to 3 weeks. 
 
Construction of RevTRE-EGFP (Reporter Gene) and RevTRE-UCP1 Vectors-  
 
The pRevTET-Off, pEGFP, pRevTRE vectors was purchased from BD 
Biosciences (Mountain View, CA). The vector was linearized with Sca1 for 
transfection into 3T3-L1 preadipocytes. Plasmid pEGFP was cut with Not1 
and then blunted with T7 DNA polymerase (Fig. 7). The vector was then 
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digested with BamH1. EGFP gene cut from pEGFP was then ligated with 
pRevTRE, which was digested with BamH1 and Hpa1. PRevTRE-EGFP was 
linearized by BsaA1 for transfection in to pRevTET-Off selected 3T3-L1 cells. 
 
 
 
 
Fig 7. Construction of pRevTRE-EGFP and pRevTRE-UCP1 vectors 
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Plasmid pCMV-Sport6-UCP1 containing the mus musculus full length 
cDNA for UCP1 was purchased from Invitrogen (Carlsbad, CA). It was 
digested with Sal1 and Xba1 to remove the UCP1 gene from the plasmid. 
pSP72, a cloning vector was purchased from Promega (Madison, WI). It was 
digested with Sal1 and Xba1 and then ligated to the UCP1 gene cut from 
pCMV-Sport6-UCP1 (Fig. 7). pSP72 was then  digested with Sal1 and Cla1 
to remove UCP1 which was further ligated into pRevTRE, digested with the 
same set of restriction enzymes. pRevTRE-UCP1 was linearized with BsaA1 
for transfection into pRevTET-Off selected 3T3-L1 preadipocytes. 
 
Retroviral Vector Transfection and Optimization- All plasmids were 
transfected by electroporation using Gene Pulsar II from Bio-Rad (Hercules, 
CA) at 240 volts and 960 micro-farads (39). Transfection protocol was 
optimized during the pRevTET-Off electroporation. Two different cells/DNA 
ratio (10^5 cells/10g DNA and 10^5 cells/20g DNA) were used. Cells were 
kept on ice prior to electroporation and were kept at room temperature after 
electroporation. The cells were then seeded in a T-25 flask and selected with 
G418 for neomycin resistance. pRevTRE-EGFP and pRevTRE-UCP1 cells 
were transfected into the pRevTET-Off selected 3T3-L1 preadipocytes as 
described above and selected with hygromycin to obtain 3T3-L1 cells that 
had either pRevTRE-EGFP or pRevTRE-UCP1 stably integrated into the 
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genome. These cells were grown up and frozen down in aliquots (15*10^4 
cells/ml) for subsequent differentiation. 
 
Detection of EGFP Expression- EGFP expression in the double stable 3T3-L1 
preadipocytes was detected using phase contrast and fluorescence 
microscopy.  These cells were then allowed to differentiate into adipocytes by 
the optimized cell culture protocol and their EGFP expression was again 
confirmed using fluorescence microscopy. 
 
Regulation of Expression Using the Tet-Off System-3T3-L1-EGFP 
preadipocytes were plated on 6 well plates (2.5*10^5 cells/well) and 
differentiated as described above. Cells were treated with doxycycline (8, 1, 
0.1 g/ml) for 72 hrs and the EGFP fluorescence levels were observed at 
specific time intervals 0hrs, 24hrs, 48hrs and 72 hrs post doxycycline 
addition. Fluorescence was detected using a SpectraMax GeminiEM from 
Molecular Devices. After 72 hrs, the cells were fed with normal maintenance 
medium and their fluorescence levels were observed after 24 hrs.   
 
Adipocytes Functional Assays- Triglyceride Assay- Mature adipocytes 
(control or expressing either EGFP or UCP1) was lysed with RIPA lysis 
buffer(Nacl, SDS, Deoxycholate, Tris-Hcl, NaF, EDTA, glycerol, Nonidet-
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P40) and their intracellular TG was measured using the triglyceride and free 
glycerol reagent purchased from Sigma (St. Louis, MO) and compared with 
the control adipocytes. The absorbance levels were measured at 540nm using 
SpectraMax 340PC plate reader purchased from Molecular Devices 
(Sunnyvale, CA). Free Fatty Acids (FFA) Assay- Culture medium from the 
mature adipocytes expressing EGFP was collected for analyzing the levels of 
free fatty acids expelled out from the cells. FFA levels were quantified using 
the Half Micro Kit purchased from Roche Applied Sciences (Indianapolis, IN) 
as per the manufacturer’s protocol using a SpectraMax 340PC plate reader 
purchased from Molecular Devices. ATP Assay- Mature adipocytes 
expressing EGFP or UCP1 were lysed with the lysis buffer provided in the 
ATP Bioluminescence HSII kit from Roche applied sciences. ATP levels were 
measured as per the manufacturer’s protocol and luminescence values were 
measured using the SpectraMax GeminiEM from Molecular Devices and 
compared with the control adipocytes. Lipolysis Assay- 3T3-L1 mature 
adipocytes were exposed to 15ng/ml of TNF- for 24 hrs. The supernatant 
was then collected and the amount of free fatty acids and free glycerol 
present were analyzed as described above. The cells were then lysed by RIPA 
buffer and their TG levels were measured as explained above. 
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RESULTS AND DISCUSSION 
Optimization of Cell Culture Protocol for Increased Differentiation of 
Preadipocytes- 3T3-L1 preadipocytes were seeded at different densities and 
allowed to reach confluence. Confluent cells were differentiated into mature 
adipocytes as described in materials and methods. As expected, cells seeded 
with lesser densities took more time to reach confluence, i.e., more mitotic 
divisions before the cells reach confluence.  Surprisingly, the degree of 
differentiation observed also varied depending on the time to reach 
confluence (Table 2). Results show that the more the number of days for the 
cells to reach confluence, the lesser is its efficiency to differentiate. Through 
these results, we were able to determine an optimum seeding density to 
attain enhanced differentiation. It is still unclear why the number of mitotic 
divisions before confluence affects the percentage of differentiation.  
 
TABLE 2 
Optimization of preadipocytes differentiation to adipocytes 
Seeding Density 
Cells/T25 flask 
Days to confluence Percentage of 
differentiation 
1x10^4 9 <10% 
5x10^4 7 10-20% 
1x10^5 6 ~50% 
2.5x10^5 5 >90% 
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Retroviral Vector Transfection and Optimization- Plasmid pRevTET-Off was 
transfected into 3T3-L1 preadipocytes by electroporation and was stably 
integrated into the cells genome. pRevTET-Off expresses the neomycin 
resistant gene. So, the cells after electroporation were selected for G418 
resistance. There was a massive cell death after a week from electroporation 
killing all the cells which don’t have the plasmid. Table 3 shows that only the 
cells having the plasmid survived. The percentage of survival was more for 
condition 1 with lower DNA compared to condition 2.  
 
TABLE 3 
Optimization of pRevTET-Off transfection (Cells:DNA ratio) 
Condition No: Amount of DNA 
(g) 
Percentage of survival upon 
selection with neomycin 
1 10 15% 
2 20 10% 
3 0 None 
4 No electroporation None 
 
 
Cells were then allowed to grow to reach ~70% confluence for the 
second electroporation.  Cells that survived from conditions 1 and conditions 
2 were used for the pRevTRE-EGFP electroporation. pRevTRE-EGFP 
expresses the gene for hygromycin resistance; Table 4 shows the percentage 
of survival upon selection with hygromycin.  
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TABLE 4 
 
 
 
Cells survived from both the electroporation have both plasmids 
pRevTET-Off and pRevTRE-EGFP. The cells from the first electroporation 
were used for transfection with pRevTRE-UCP1. The control cells died 
during this electroporation showing again the survival of only those cells 
with the gene. Again, approximately 10% of the cells survived the 
electroporation. The double stable EGFP and UCP1 cells were then allowed 
to differentiate into mature adipocytes. 
 
Detection of EGFP Expression in 3T3-L1 Adipocytes- EGFP was chosen as 
the reporter gene as its expression can be easily detected using a a 
fluorescence microscope. EGFP expressing double stable 3T3-L1 
preadipocytes are shown using phase contrast and fluorescence microscopy 
(Fig 8A). These cells were then allowed to differentiate into mature 
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adipocytes and their EGFP expression was again confirmed using 
fluorescence microscopy (Fig 8B). 
 
A 
 
B 
 
Fig 8(A) Phase contrast images of preadipocytes and mature 
adipocytes; (B) Fluorescence images of preadipocytes and mature 
adipocytes. 
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Regulation of EGFP Expression with DOX- Expression of EGFP was 
modulated using the chemical inducer doxycycline. Addition of doxycycline in 
a Tet-Off system decreases the binding affinity between the regulatory 
protein (transcription factor-tTA) and its binding site (response element) in a 
dose dependent manner. Since binding of the TF to the response element 
directly relates to the level of transcription of the gene, the expression of 
EGFP (or any gene) can be regulated. Doxycycline assay was performed over 
a four day period. It should be noted that the half-life of EGFP is around 24 
hours. Hence a detectable decrease in fluorescence levels was observed only 
after 24 hours. Since half-life of doxycycline in serum is 24 hours, 
doxycycline containing media was added to the cells every 24 hours. Cells 
were exposed to DOX medium for 72 hours and replaced with normal 
maintenance medium for the last 24 hours of the experiment. Three different 
concentrations of doxycycline were used covering an 80 fold range in 
concentration. Figure 9A shows that fluorescence values in all the wells 
decreased significantly during the 72 hour period of the assay. When 
doxycycline was removed at the end of 72 hours, fluorescence levels again 
started to increase to the original levels. Figure 9B shows the percentage 
reduction in fluorescence during the 3 day period for different concentrations 
of doxycycline. In addition, the percentage reduction in fluorescence for 
different time points and time taken for a specific reduction in fluorescence  
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A 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
Fig.9 (A) A time course plot on the effect of different concentrations 
of doxycycline on EGFP expression levels; (B) Effect of different 
concentrations of doxycycline on percentage reduction in 
fluorescence 
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for different concentrations of doxycycline remained almost constant (Figure 
9B & Table 6). This assay clearly shows that gene expression in adipocytes 
can be regulated by doxycycline with the RevTET-Off system. 
 
 
TABLE 5 
Analysis of fluorescence values obtained from the doxycycline assay 
 
Time taken for 20% 
reduction in 
fluorescence 
Time taken for 40% 
reduction in 
fluorescence 
Time taken for 60% 
reduction in 
fluorescence 
Conc(g/ml) Time 
(hrs) 
 
Conc(g/ml) Time 
(hrs) 
 
Conc(g/ml) Time 
(hrs) 
 
8 19 8 32 8 44 
1 23.5 1 35 1 44 
0.1 17 0.1 32 0.1 46 
% reduction in 
fluorescence at 20 
hrs 
% reduction in 
fluorescence at 40 
hrs 
% reduction in 
fluorescence at 60 
hrs 
Conc(g/ml) % 
reduction 
 
Conc(g/ml) % 
reduction 
 
Conc(g/ml) % 
reduction 
 
8 21 8 55 8 83 
1 16 1 52 1 83 
0.1 25 0.1 51 0.1 81 
 
 
Adipocytes Metabolic Assays- Triglyceride Assay- Since the plasmids 
pRevTet-off and pRevTRE-EGFP are randomly integrated in the adipocyte 
genome, it is important to determine if the site of integration impacted the 
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metabolic functions of the adipocytes. Since adipocytes, store fat in the form 
of triglycerides, determining the levels of TG is an extremely pertinent assay 
for adipocyte function. Therefore, we quantified the triglyceride levels in 
adipocytes expressing EGFP and compared it to that seen in control 
(untransfected) adipocytes. Table 6 shows that there is no statistically 
significant difference between the TG values of the control adipocytes and 
EGFP expressing adipocytes. 
 
TABLE 6 
Triglyceride assay on EGFP cells 
TG levels (mol glycerol/g-DNA) 
Control Adipocytes 0.232 +/- 0.067 
EGFP expressing 
adipocytes 
0.248 +/- 0.072 
 
 
Lipolysis Assay- When TG are broken down in adipocytes, they are 
converted to glycerol and FFA. Both glycerol and FFA, when in excess are 
expelled from the cells. Lipolysis or Adipolysis is another important 
functional assay for the mature adipocytes. To show the RevTet system has 
no effect on lipolysis, we induced TG break down in adipocytes by exposing 
with TNF-, a well known cytokine to induce adipolysis. Intracellular TG, 
extracellular glycerol and extracellular FFA assays were performed on the 
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EGFP cells and their levels were compared with the control adipocytes. Fig 
10 shows a strong increase in the extracellular FFA and a 29% reduction the 
intracellular TG levels and a 14% increase in the extracellular glycerol 
levels. This assay clearly shows that the EGFP expressing cells respond to 
TNF- stimulation in a manner similar to that reported in the literature 
(11).    
 
 
Fig.10. Lipolysis assay showing the difference in intracellular TG, 
extracellular FFA and extracellular glycerol between EGFP 
expressing cells and EGFP cells induced with TNF- 
 
Functional Evaluation of UCP1 Expressing Adipocytes- Dissipation of the 
proton gradient in the adipocytes expressing UCP1 can result in changes in 
the levels of the metabolites such as triglycerides, glycerol and free fatty 
  
34 
acids in the cell. To characterize these changes, the levels of these functional 
markers in the UCP1 expressing cells were determined and compared with 
the control adipocytes. Figure 11 shows a 83% decrease in the intracellular 
TG in UCP1 cells (compared to the control) which suggests an increase in 
lipolysis. The intracellular FFA levels also decreased by 85%, showing an 
increase in fatty acid oxidation.   
 
Percentage Increase/Decrease in UCP1 
compared to control adipocytes
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Fig.11. Percentage change in intracellular glycerol, intracellular TG, ATP, 
intracellular FFA and extracellular FFA in UCP1 compared to the control 
adipocytes 
 
The levels of intracellular glycerol and extracellular FFA changes 
were also determined and showed decrease when compared with the control. 
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As discussed previously, a reduction in the proton gradient will cause a 
decline in ATP synthesis. It is important to find whether a reduction in ATP 
synthesis caused by UCP1 will decrease the TG content in the adipocytes to 
maintain the ATP levels inside the cell through increased fat oxidation. 
Figure 11 shows that ATP levels remain almost constant for UCP1 
expressing cells when compared to the control showing the cell has the 
capacity to recover from ATP depletion by breaking down TG and increasing 
fatty acid oxidation.  
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CONCLUSIONS 
The RevTet-Off system was shown as an efficient method to transfect 
genes of interest (EGFP, UCP1) into 3T3-L1 preadipocytes. Metabolic assays 
– Triglyceride, free fatty acid, and lipolysis assays performed on EGFP 
expressing cells clearly showed that RevTet-Off transfection has no effect on 
preadipocytes differentiation or on adipocytes function. Through the 
doxycycline assay, RevTet-Off system was shown to act as an on/off switch 
for gene expression of the transfected vectors in 3T3-L1 adipocytes.  
Metabolic assays – triglyceride, free fatty acid, ATP, and glycerol 
assays performed on UCP1 expressing cells showed reduced TG and FFA 
levels but showed no change in ATP levels. We conclude that UCP1 
expressing cells have the capacity to recover from ATP depletion by breaking 
down their triglycerides and by increasing fatty acid oxidation.  
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